Aristea Announces Plans for Phase III Development of AR-YU-69
A Drug for Alzheimer’s Disease
Sci. Transl. Med. 2, 61rv6 (2010).
“Researching Drugs to Insure Sound Drug Developments”
To Achieve Regulatory Approval
The Drug Must Possess Efficacy and
The Development Must Allow the Drug to Exhibit This Efficacy.